Castleark Management’s MiMedx Group MDXG Stock Holding History

Castleark Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-709,950	Closed	-$8.23M	–	387
2015 Q2	$8.23M	Buy	709,950 +2,850	+0.4%	+$29.3K	0.22%	131
2015 Q1	$7.35M	Buy	707,100 +285,100	+68%	+$2.67M	0.18%	157
2014 Q4	$4.87M	Buy	+422,000	New	+$4.17M	0.13%	167

Other funds holding MDXG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Castleark Management's MDXG Position: Q3 2015 in Review

Castleark Management sold out of MiMedx Group (MDXG) in Q3 2015, closing a stake of 709,950 shares — an estimated $8.23M sold.

Castleark Management first reported a position in MDXG in Q4 2014 and held it in 3 quarters. The position peaked at $8.23M in Q2 2015. 178 funds tracked by Wall St. Rank hold MDXG as of Q3 2015.

Castleark Management reported no remaining MiMedx Group position as of Q3 2015 after selling out during the quarter.
Castleark Management sold 709,950 MiMedx Group shares in Q3 2015, an estimated $8.23M.
Castleark Management first reported a position in MiMedx Group in Q4 2014 and held it in 3 quarters.
Castleark Management's MiMedx Group position peaked at $8.23M in Q2 2015.
178 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2015.

Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.